Literature DB >> 31202740

5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT.

Yuka Otaki1, Julian Betancur1, Tali Sharir2, Lien-Hsin Hu3, Heidi Gransar1, Joanna X Liang1, Peyman N Azadani1, Andrew J Einstein4, Mathews B Fish5, Terrence D Ruddy6, Philipp A Kaufmann7, Albert J Sinusas8, Edward J Miller8, Timothy M Bateman9, Sharmila Dorbala10, Marcelo Di Carli10, Balaji K Tamarappoo1, Guido Germano1, Damini Dey1, Daniel S Berman1, Piotr J Slomka11.   

Abstract

OBJECTIVES: This study compared the ability of automated myocardial perfusion imaging analysis to predict major adverse cardiac events (MACE) to that of visual analysis.
BACKGROUND: Quantitative analysis has not been compared with clinical visual analysis in prognostic studies.
METHODS: A total of 19,495 patients from the multicenter REFINE SPECT (REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT) study (64 ± 12 years of age, 56% males) undergoing stress Tc-99m-labeled single-photon emission computed tomography (SPECT) myocardial perfusion imaging were followed for 4.5 ± 1.7 years for MACE. Perfusion abnormalities were assessed visually and categorized as normal, probably normal, equivocal, or abnormal. Stress total perfusion deficit (TPD), quantified automatically, was categorized as TPD = 0%, TPD >0% to <1%, ≤1% to <3%, ≤3% to <5%, ≤5% to ≤10%, or TPD >10%. MACE consisted of death, nonfatal myocardial infarction, unstable angina, or late revascularization (>90 days). Kaplan-Meier and Cox proportional hazards analyses were performed to test the performance of visual and quantitative assessments in predicting MACE.
RESULTS: During follow-up examinations, 2,760 (14.2%) MACE occurred. MACE rates increased with worsening of visual assessments, that is, the rate for normal MACE was 2.0%, 3.2% for probably normal, 4.2% for equivocal, and 7.4% for abnormal (all p < 0.001). MACE rates increased with increasing stress TPD from 1.3% for the TPD category of 0% to 7.8% for the TPD category of >10% (p < 0.0001). The adjusted hazard ratio (HR) for MACE increased even in equivocal assessment (HR: 1.56; 95% confidence interval [CI]: 1.37 to 1.78) and in the TPD category of ≤3% to <5% (HR: 1.74; 95% CI: 1.41 to 2.14; all p < 0.001). The rate of MACE in patients visually assessed as normal still increased from 1.3% (TPD = 0%) to 3.4% (TPD ≥5%) (p < 0.0001).
CONCLUSIONS: Quantitative analysis allows precise granular risk stratification in comparison to visual reading, even for cases with normal clinical reading.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  major adverse cardiac event; myocardial perfusion imaging; prognosis; quantification

Year:  2019        PMID: 31202740      PMCID: PMC6899217          DOI: 10.1016/j.jcmg.2019.02.028

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  29 in total

1.  The increasing role of quantification in clinical nuclear cardiology: the Emory approach.

Authors:  Ernest V Garcia; Tracy L Faber; C David Cooke; Russell D Folks; Ji Chen; Cesar Santana
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

Review 2.  The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis.

Authors:  Louise D Metz; Mary Beattie; Robert Hom; Rita F Redberg; Deborah Grady; Kirsten E Fleischmann
Journal:  J Am Coll Cardiol       Date:  2006-12-29       Impact factor: 24.094

3.  A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera.

Authors:  Sanjiv S Gambhir; Daniel S Berman; Jack Ziffer; Michael Nagler; Martin Sandler; Jim Patton; Brian Hutton; Tali Sharir; Shlomo Ben Haim; Simona Ben Haim
Journal:  J Nucl Med       Date:  2009-04       Impact factor: 10.057

4.  Optimization of SPECT Measurement of Myocardial Blood Flow with Corrections for Attenuation, Motion, and Blood Binding Compared with PET.

Authors:  R Glenn Wells; Brian Marvin; Marlie Poirier; Jennifer Renaud; Robert A deKemp; Terrence D Ruddy
Journal:  J Nucl Med       Date:  2017-06-13       Impact factor: 10.057

5.  Risk stratification using line source attenuation correction with rest/stress Tc-99m sestamibi SPECT myocardial perfusion imaging.

Authors:  Afrooz Ardestani; Alan W Ahlberg; Deborah M Katten; Krista Santilli; Donna M Polk; Timothy M Bateman; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-11-21       Impact factor: 5.952

6.  Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.

Authors:  Leslee J Shaw; Robert Hendel; Salvador Borges-Neto; Michael S Lauer; Naomi Alazraki; Joy Burnette; Elizabeth Krawczynska; Manuel Cerqueira; Jamshid Maddahi
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

7.  Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation.

Authors:  Daniel S Berman; Aiden Abidov; Xingping Kang; Sean W Hayes; John D Friedman; Maria G Sciammarella; Ishac Cohen; James Gerlach; Parker B Waechter; Guido Germano; Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

8.  Prognostic value of quantitative high-speed myocardial perfusion imaging.

Authors:  Ryo Nakazato; Daniel S Berman; Heidi Gransar; Mark Hyun; Romalisa Miranda-Peats; Faith C Kite; Sean W Hayes; Louise E J Thomson; John D Friedman; Alan Rozanski; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2012-10-12       Impact factor: 5.952

9.  Prognostic Value of Combined Clinical and Myocardial Perfusion Imaging Data Using Machine Learning.

Authors:  Julian Betancur; Yuka Otaki; Manish Motwani; Mathews B Fish; Mark Lemley; Damini Dey; Heidi Gransar; Balaji Tamarappoo; Guido Germano; Tali Sharir; Daniel S Berman; Piotr J Slomka
Journal:  JACC Cardiovasc Imaging       Date:  2017-10-18

10.  Are shades of gray prognostically useful in reporting myocardial perfusion single-photon emission computed tomography?

Authors:  Aiden Abidov; Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Xingping Kang; Ling De Yang; Louise Thomson; Guido Germano; Piotr Slomka; Daniel S Berman
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-11       Impact factor: 7.792

View more
  18 in total

1.  Leveraging latest computer science tools to advance nuclear cardiology.

Authors:  Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2019-09-05       Impact factor: 5.952

2.  Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter Study.

Authors:  Balaji K Tamarappoo; Yuka Otaki; Tali Sharir; Lien-Hsin Hu; Heidi Gransar; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Evann Eisenberg; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

3.  Do we need dedicated cardiac SPECT systems?

Authors:  Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2019-10-24       Impact factor: 5.952

4.  Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry.

Authors:  Keiichiro Kuronuma; Robert J H Miller; Yuka Otaki; Serge D Van Kriekinge; Marcio A Diniz; Tali Sharir; Lien-Hsin Hu; Heidi Gransar; Joanna X Liang; Tejas Parekh; Paul B Kavanagh; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Balaji K Tamarappoo; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  Circ Cardiovasc Imaging       Date:  2021-07-20       Impact factor: 7.792

Review 5.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952

6.  Early onset of left ventricular regional asynchrony in arteries with sub-clinical stenosis.

Authors:  Andrew Van Tosh; John R Votaw; C David Cooke; J Jane Cao; Christopher J Palestro; Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2020-07-23       Impact factor: 5.952

7.  Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry.

Authors:  Donghee Han; Alan Rozanski; Heidi Gransar; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Lien-Hsin Hu; Guido Germano; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  Diabetes Care       Date:  2019-11-27       Impact factor: 17.152

8.  Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry.

Authors:  Eyal Klein; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Yuka Otaki; Heidi Gransar; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2020-09-14       Impact factor: 5.952

9.  Visually estimated coronary artery calcium score improves SPECT-MPI risk stratification.

Authors:  Cvetan Trpkov; Alexei Savtchenko; Zhiying Liang; Patrick Feng; Danielle A Southern; Stephen B Wilton; Matthew T James; Erin Feil; Ilias Mylonas; Robert J H Miller
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-19

10.  Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery Disease.

Authors:  Yuka Otaki; Ananya Singh; Paul Kavanagh; Robert J H Miller; Tejas Parekh; Balaji K Tamarappoo; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Sebastien Cadet; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  JACC Cardiovasc Imaging       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.